News from celladon corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( Bloomberg:RTRKS,RICS:RTRKS)

Dec 11, 2013, 08:30 ET

Celladon Corporation Announces Receipt of EMA Scientific Advice for MYDICAR® and Initiation of AGENT-HF Trial

 Celladon Corporation, a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the...

Nov 18, 2013, 16:58 ET

Celladon Corporation Announces Oral Presentation at American Heart Association of Long Term Follow-Up Results from the MYDICAR CUPID 1 Trial in Advanced Heart Failure

 Celladon Corporation, a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the...

Oct 18, 2013, 08:30 ET

Celladon Corporation Appoints Michael Narachi as Chairman of the Board of Directors

Celladon Corporation, a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the field...

Oct 11, 2013, 08:28 ET

Celladon Corporation Files Registration Statement for Proposed Initial Public Offering

Celladon Corporation, a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the field...

Sep 26, 2013, 11:20 ET

Celladon Corporation Announces Publication of Long Term Follow-Up Results from the MYDICAR CUPID 1 Trial in Advanced Heart Failure

 Celladon Corporation, a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the...

Sep 10, 2013, 08:08 ET

Celladon Corporation Announces Appointment of Gregg Alton and Graham Cooper to its Board of Directors

 Celladon Corporation, a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the...

Jul 30, 2013, 07:30 ET

Celladon Corporation Announces Pre-clinical Study Demonstrating Inhalable MYDICAR Reverses Pulmonary Arterial Hypertension (PAH)

Celladon Corporation, a clinical-stage biotechnology company committed to applying its first-mover, leadership position in the field of SERCA...

May 29, 2013, 16:00 ET

Celladon Corporation Selected as Winner of Red Herring's "Top 100 North America Tech Startup"

Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases...

May 08, 2013, 09:00 ET

Celladon Corporation and SIRO Clinpharm Announce Presentation at "Statisticians in the Pharmaceutical Industry International Conference"

 Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular...

May 07, 2013, 12:00 ET

Celladon Corporation is a Finalist for the 2013 Red Herring Top 100 North America Award

 Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular...

Mar 29, 2013, 07:00 ET

Celladon Corporation To Present at BioCentury Future Leaders in the Biotech Industry Conference

Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases,...

Jan 23, 2013, 08:30 ET

Celladon Corporation Receives Notice of Allowance from United States Patent and Trademark Office

Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases,...

Dec 11, 2012, 16:30 ET

Celladon Corporation Announces First European Patient Dosed in CUPID Phase 2b Trial of MYDICAR® for Advanced Heart Failure

Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases,...

Oct 02, 2012, 06:00 ET

Lonza and Celladon Announce Manufacturing Agreement for MYDICAR®

Lonza, a global leader in the field of viral therapy manufacturing, and Celladon Corporation, a biopharmaceutical company focused on the discovery...

Sep 19, 2012, 09:00 ET

Celladon Corporation Named a 2012 Fierce 15 Company by FierceBiotech

Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases,...

Aug 29, 2012, 09:30 ET

Celladon Corporation Announces First Patient Dosed in CUPID Phase 2b Trial of MYDICAR® for Advanced Heart Failure

 Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular...

Jul 19, 2012, 09:00 ET

Celladon Corporation Receives Patent from United States Patent and Trademark Office

 Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular...

Jun 18, 2012, 09:15 ET

Celladon Corporation Receives Notice of Allowance from European Patent Office

 Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular...

Feb 15, 2012, 09:00 ET

Celladon Corporation Completes $43 Million Financing to Advance MYDICAR® for the Treatment of Heart Failure

Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases,...

Dec 12, 2011, 10:00 ET

Celladon Corporation Receives FDA Fast Track Designation for Its Investigational Agent MYDICAR® for the Treatment of Heart Failure

 Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases,...